Tag: Imlifidase
Imlifidase phase 2 study enrolment by Hansa Biopharma for patients with Guillain-Barré syndrome is already complete.
The phase 2 recruitment for Hansa Biopharma’s imlifidase research in Guillain-Barré syndrome has been completed, according to the…
